RGS12 represses oral squamous cell carcinoma by driving M1 polarization of tumor-associated macrophages via controlling ciliary MYCBP2/KIF2A signaling

Abstract Tumor-associated macrophages (TAMs) play crucial roles in tumor progression and immune responses. However, mechanisms of driving TAMs to antitumor function remain unknown. Here, transcriptome profiling analysis of human oral cancer tissues indicated that regulator of G protein signaling 12...

Full description

Saved in:
Bibliographic Details
Main Authors: Gongsheng Yuan (Author), Shuting Yang (Author), Shuying Yang (Author)
Format: Book
Published: Nature Publishing Group, 2023-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_db72b2a7b0ff49bca0891dfa8e6124ca
042 |a dc 
100 1 0 |a Gongsheng Yuan  |e author 
700 1 0 |a Shuting Yang  |e author 
700 1 0 |a Shuying Yang  |e author 
245 0 0 |a RGS12 represses oral squamous cell carcinoma by driving M1 polarization of tumor-associated macrophages via controlling ciliary MYCBP2/KIF2A signaling 
260 |b Nature Publishing Group,   |c 2023-02-01T00:00:00Z. 
500 |a 10.1038/s41368-023-00216-5 
500 |a 2049-3169 
520 |a Abstract Tumor-associated macrophages (TAMs) play crucial roles in tumor progression and immune responses. However, mechanisms of driving TAMs to antitumor function remain unknown. Here, transcriptome profiling analysis of human oral cancer tissues indicated that regulator of G protein signaling 12 (RGS12) regulates pathologic processes and immune-related pathways. Mice with RGS12 knockout in macrophages displayed decreased M1 TAMs in oral cancer tissues, and extensive proliferation and invasion of oral cancer cells. RGS12 increased the M1 macrophages with features of increased ciliated cell number and cilia length. Mechanistically, RGS12 associates with and activates MYC binding protein 2 (MYCBP2) to degrade the cilia protein kinesin family member 2A (KIF2A) in TAMs. Our results demonstrate that RGS12 is an essential oral cancer biomarker and regulator for immunosuppressive TAMs activation. 
546 |a EN 
690 |a Dentistry 
690 |a RK1-715 
655 7 |a article  |2 local 
786 0 |n International Journal of Oral Science, Vol 15, Iss 1, Pp 1-11 (2023) 
787 0 |n https://doi.org/10.1038/s41368-023-00216-5 
787 0 |n https://doaj.org/toc/2049-3169 
856 4 1 |u https://doaj.org/article/db72b2a7b0ff49bca0891dfa8e6124ca  |z Connect to this object online.